14-day Premium Trial Subscription Try For FreeTry Free
Companies have ongoing collaboration in first-line metastatic triple-negative breast cancerImmunomedics also announces Phase 2 NeoSTAR study in neoadjuvant triple-negative breast cancer has begun pati
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Akero Therapeutics Inc (...

Immunomedics: A Solid Cancer Research Play

03:29pm, Wednesday, 08'th Jul 2020
The company has a strong pipeline of antibody-drug conjugates Continue reading...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) AbbVie Inc (NYSE: ABBV)...
Is (IMMU) Outperforming Other Medical Stocks This Year?
Shares of Immunomedics (IMMU) rise after it announces positive phase III data for its breast-cancer drug, Trodelvy.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) * ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) * Akero
Immunomedics reports positive phase 3 cancer data. ADC Therapeutics partial clinical hold lifted.
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) ACADIA Pharmaceuticals Inc...
Uber shares get a boost on news of a deal with Postmates. Spotify falls on an analyst downgrade.
Shares of Immunomedics Inc. undefined gained 6.9% in trading on Monday after the drugmaker said a confirmatory Phase 3 clinical trial of its breast-cancer...
Shares of Immunomedics Inc. gained 6.9% in trading on Monday after the drugmaker said a confirmatory Phase 3 clinical trial of its breast-cancer drug Trodelvy met its primary and secondary endpoints.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE